Survival Outcomes in Lymph Node-Positive Merkel Cell Carcinoma (Stage III): A Comparison Between Known and Unknown Primary Tumors and Their Sun Exposure Sites
Medical Sciences · 11.04.2026 · 14 (2) · 193
DOI: 10.3390/medsci14020193 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Medical Sciences, online erschienen am 11.04.2026. Verfasst von Ronen Brenner und 14 weiteren Autor:innen. Beteiligte Einrichtung: Oncology Institute, Edith Wolfson Medical Center, Holon 58220, Israel. Hauptthemen laut MEDLINE: Carcinoma, Merkel Cell, Neoplasms, Unknown Primary, Skin Neoplasms, Sunlight. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Merkel cell carcinoma (MCC) is a rare, aggressive skin cancer, with prognosis influenced by tumor location and primary status. This study evaluated clinicopathological features and survival outcomes in patients with MCC from multiple centers in Israel.
Methods
Data on demographics, tumor characteristics, lymph node (LN) involvement, treatment, and survival were collected. Patients were stratified by primary tumor status (known vs. unknown) and tumor location (sun-exposed vs. non-sun-exposed). Disease-free survival (DFS) and overall survival (OS) were estimated using Kaplan–Meier analysis, and multivariate analyses were performed.
Results
The cohort included 80 patients diagnosed with stage 3 (with LN involvement) MCC, of whom 52 (65%) had primary MCC with lymph node involvement, and 28 patients (35%) with unknown primary MCC. The majority were male (81.3%), with a median age of 71.2 years (range, 37–92). The median DFS and OS for the entire cohort were 24 and 32 months, respectively. Patients with unknown primary tumors had longer DFS (34 vs. 18 months; p = 0.0503) and OS (43 vs. 28 months; p = 0.0362) compared with those with known primary MCC. Non-sun-exposed tumors were associated with longer median DFS (32 vs. 18.5 months; p = 0.0663) and OS (41 vs. 23 months; p = 0.0353). Five-year survival analysis showed improved outcomes in patients with unknown primary tumors (DFS 54% vs. 35%, p = 0.04; OS 57% vs. 42%, p = 0.03) and in non-sun-exposed tumors (DFS 51% vs. 33%, p = 0.05; OS 57% vs. 40%, p = 0.04).
Conclusions
Unknown primary status and non-sun-exposed tumor location are potentially associated with improved long-term survival in patients with MCC. These findings highlight the prognostic importance of tumor origin and anatomical site in MCC management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Oncology Institute, Edith Wolfson Medical Center, Holon 58220, Israel.
- Faculty of Medicine, Tel Aviv University, Tel Aviv-Yafo 69978, Israel.
- Medical School for International Health, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva 84105, Israel.
- The Legacy Heritage Cancer Center, Dr. Larry Norton Institute, Soroka Medical Center, Beer Sheva 84105, Israel.
- Institute of Oncology, Kaplan Medical Center, Faculty of Medicine, Hebrew University, Jerusalem 91905, Israel.
- Institute of Oncology, Davidoff Center, Rabin Medical Center, Beilinson Hospital, Petah Tikva 49414, Israel.
ORCID-Profile: Keren Rouvinov, Abed Agbarya, Walid Shalata
Zitieren
APA
Brenner, R., Edri, H. T. F., El-Saied, S., Berezhnov, I., Ievko, A., Rouvinov, K., Turaieva, S., Meirovitz, A., Tairov, T., Fenig, S., Yasin, N. A., Yakobson, A., Fenig, E., Agbarya, A., & Shalata, W. (2026). Survival Outcomes in Lymph Node-Positive Merkel Cell Carcinoma (Stage III): A Comparison Between Known and Unknown Primary Tumors and Their Sun Exposure Sites. Medical Sciences, 14(2), 193. https://doi.org/10.3390/medsci14020193
Vancouver
Brenner R, Edri HTF, El-Saied S, Berezhnov I, Ievko A, Rouvinov K, et al. Survival Outcomes in Lymph Node-Positive Merkel Cell Carcinoma (Stage III): A Comparison Between Known and Unknown Primary Tumors and Their Sun Exposure Sites. Medical Sciences. 2026;14(2):193. doi:10.3390/medsci14020193
BibTeX
@article{Brenner2026,
author = {Brenner, Ronen and Edri, Hanna T Frumin and El-Saied, Sabri and Berezhnov, Ilia and Ievko, Anna and Rouvinov, Keren and Turaieva, Sofiia and Meirovitz, Amichay and Tairov, Tanzilya and Fenig, Shlomit and Yasin, Nashat Abu and Yakobson, Alexander and Fenig, Eyal and Agbarya, Abed and Shalata, Walid},
title = {Survival Outcomes in Lymph Node-Positive Merkel Cell Carcinoma (Stage III): A Comparison Between Known and Unknown Primary Tumors and Their Sun Exposure Sites},
journal = {Medical Sciences},
year = {2026},
volume = {14},
number = {2},
pages = {193},
doi = {10.3390/medsci14020193}
}
EUVIMED